280 related articles for article (PubMed ID: 27447484)
1. Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host Cells.
Deiser K; Stoycheva D; Bank U; Blankenstein T; Schüler T
PLoS One; 2016; 11(7):e0159690. PubMed ID: 27447484
[TBL] [Abstract][Full Text] [Related]
2. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP
J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927
[TBL] [Abstract][Full Text] [Related]
3. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation.
Allard EL; Hardy MP; Leignadier J; Marquis M; Rooney J; Lehoux D; Labrecque N
Eur J Immunol; 2007 Nov; 37(11):3069-77. PubMed ID: 17918202
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
6. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
[TBL] [Abstract][Full Text] [Related]
7. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1.
Hartung E; Becker M; Bachem A; Reeg N; Jäkel A; Hutloff A; Weber H; Weise C; Giesecke C; Henn V; Gurka S; Anastassiadis K; Mages HW; Kroczek RA
J Immunol; 2015 Feb; 194(3):1069-79. PubMed ID: 25520399
[TBL] [Abstract][Full Text] [Related]
8. Signaling thresholds govern heterogeneity in IL-7-receptor-mediated responses of naïve CD8(+) T cells.
Palmer MJ; Mahajan VS; Chen J; Irvine DJ; Lauffenburger DA
Immunol Cell Biol; 2011 Jul; 89(5):581-94. PubMed ID: 21339767
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.
Ren Z; Guo J; Liao J; Luan Y; Liu Z; Sun Z; Liu X; Liang Y; Peng H; Fu YX
Clin Cancer Res; 2017 Jan; 23(1):193-203. PubMed ID: 27354469
[TBL] [Abstract][Full Text] [Related]
10. Non-redundant role for IL-7R signaling for the survival of CD8+ memory T cells.
Carrio R; Rolle CE; Malek TR
Eur J Immunol; 2007 Nov; 37(11):3078-88. PubMed ID: 17935075
[TBL] [Abstract][Full Text] [Related]
11. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
[TBL] [Abstract][Full Text] [Related]
12. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
13. IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector.
Colombetti S; Lévy F; Chapatte L
Blood; 2009 Jun; 113(26):6629-37. PubMed ID: 19383968
[TBL] [Abstract][Full Text] [Related]
14. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
[TBL] [Abstract][Full Text] [Related]
15. Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8
Qiao J; Liu Z; Dong C; Luan Y; Zhang A; Moore C; Fu K; Peng J; Wang Y; Ren Z; Han C; Xu T; Fu YX
Cancer Cell; 2019 Jun; 35(6):901-915.e4. PubMed ID: 31185213
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity of human effector CD8+ T cells.
Takata H; Naruto T; Takiguchi M
Blood; 2012 Feb; 119(6):1390-8. PubMed ID: 22174157
[TBL] [Abstract][Full Text] [Related]
17. The Antitumor Effects of Vaccine-Activated CD8
Wu S; Zhu W; Peng Y; Wang L; Hong Y; Huang L; Dong D; Xie J; Merchen T; Kruse E; Guo ZS; Bartlett D; Fu N; He Y
Cancer Immunol Res; 2017 Oct; 5(10):908-919. PubMed ID: 28851693
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.
Schluns KS; Kieper WC; Jameson SC; Lefrançois L
Nat Immunol; 2000 Nov; 1(5):426-32. PubMed ID: 11062503
[TBL] [Abstract][Full Text] [Related]
19. IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization.
Lacombe MH; Hardy MP; Rooney J; Labrecque N
J Immunol; 2005 Oct; 175(7):4400-7. PubMed ID: 16177081
[TBL] [Abstract][Full Text] [Related]
20. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]